BG101338A - Dna encoding human papillomavirus type 6a - Google Patents
Dna encoding human papillomavirus type 6aInfo
- Publication number
- BG101338A BG101338A BG101338A BG10133897A BG101338A BG 101338 A BG101338 A BG 101338A BG 101338 A BG101338 A BG 101338A BG 10133897 A BG10133897 A BG 10133897A BG 101338 A BG101338 A BG 101338A
- Authority
- BG
- Bulgaria
- Prior art keywords
- human papillomavirus
- papillomavirus type
- dna encoding
- encoding human
- type
- Prior art date
Links
- 241001502561 Human papillomavirus type 6a Species 0.000 title 1
- 241000701806 Human papillomavirus Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31046894A | 1994-09-22 | 1994-09-22 | |
PCT/US1995/011859 WO1996009375A1 (en) | 1994-09-22 | 1995-09-18 | Dna encoding human papillomavirus type 6a |
Publications (1)
Publication Number | Publication Date |
---|---|
BG101338A true BG101338A (en) | 1997-10-31 |
Family
ID=23202654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG101338A BG101338A (en) | 1994-09-22 | 1997-03-18 | Dna encoding human papillomavirus type 6a |
Country Status (16)
Country | Link |
---|---|
US (1) | US6290965B1 (xx) |
EP (1) | EP0782615A4 (xx) |
JP (1) | JPH10506014A (xx) |
AU (1) | AU694269B2 (xx) |
BG (1) | BG101338A (xx) |
BR (1) | BR9509076A (xx) |
CA (1) | CA2200582C (xx) |
CZ (1) | CZ87597A3 (xx) |
FI (1) | FI121507B (xx) |
HU (1) | HUT77337A (xx) |
NO (1) | NO971347L (xx) |
NZ (1) | NZ293461A (xx) |
PL (1) | PL319294A1 (xx) |
RU (1) | RU2177999C2 (xx) |
SK (1) | SK35897A3 (xx) |
WO (1) | WO1996009375A1 (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6962981B1 (en) * | 1996-03-25 | 2005-11-08 | Medarex, Inc. | Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
PT1105466E (pt) * | 1998-08-14 | 2006-07-31 | Merck & Co Inc | Processo para a purificacao de particulas tipo virus do papilomavirus humano |
CN1100835C (zh) * | 1998-10-30 | 2003-02-05 | 中国科学院感光化学研究所 | 加入纳米无机化合物粒子的钛溶胶-凝胶涂料及其制法和用途 |
GB0017990D0 (en) * | 2000-07-21 | 2000-09-13 | Glaxo Group Ltd | Papilloma virus sequences |
WO2004081178A2 (en) * | 2003-03-06 | 2004-09-23 | Indiana University Research And Technology Corporation | Methods and composition for producing infectious hpv stocks |
IL156670A0 (en) * | 2003-06-26 | 2004-01-04 | Zvi Zolotariov | Aloe suppositories |
US20090053261A1 (en) * | 2005-09-08 | 2009-02-26 | Lindbo John A | Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications |
US20080160040A1 (en) * | 2004-04-15 | 2008-07-03 | Ghim Shin-Je | Plant-produced compositions for treating papillomavirus infection and related methods |
CA2588581C (en) | 2004-12-08 | 2011-05-31 | Gen-Probe Incorporated | Detection of nucleic acids from multiple types of human papillomaviruses |
US8084207B2 (en) * | 2005-03-03 | 2011-12-27 | Ibis Bioscience, Inc. | Compositions for use in identification of papillomavirus |
US20070031826A1 (en) * | 2005-08-05 | 2007-02-08 | My Gene | Diagnostic kit for determining the genotype of a human papilloma virus and method of using thereof |
KR100904844B1 (ko) * | 2006-08-28 | 2009-06-25 | 성균관대학교산학협력단 | 인유두종 바이러스(hpv)유전자를 포함하는자궁경부암의 치료 또는 예방용 dna 백신 |
PT2227546T (pt) * | 2007-12-21 | 2016-08-12 | Novartis Ag | Vector de expressão em mamíferos |
WO2011149897A1 (en) | 2010-05-25 | 2011-12-01 | Qiagen Gaithersburg, Inc. | Fast results hybrid capture assay and associated strategically-truncated probes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1835029A1 (en) * | 1992-06-25 | 2007-09-19 | Georgetown University | Papillomavirus vaccines |
JP3863559B2 (ja) * | 1994-05-16 | 2006-12-27 | メルク エンド カンパニー インコーポレーテッド | 乳頭腫ウィルスワクチン |
AR004464A1 (es) * | 1994-11-14 | 1998-12-16 | Merck Sharp & Dohme | Un metodo para producir una proteina de capside de papilomavirus |
IL117591A0 (en) * | 1995-03-30 | 1996-07-23 | Merck & Co Inc | Synthetic DNA encoding human papillomavirus type 11 L1 protein |
-
1995
- 1995-09-18 BR BR9509076A patent/BR9509076A/pt not_active Application Discontinuation
- 1995-09-18 CA CA002200582A patent/CA2200582C/en not_active Expired - Lifetime
- 1995-09-18 HU HU9702290A patent/HUT77337A/hu unknown
- 1995-09-18 SK SK358-97A patent/SK35897A3/sk unknown
- 1995-09-18 PL PL95319294A patent/PL319294A1/xx unknown
- 1995-09-18 EP EP95933148A patent/EP0782615A4/en not_active Ceased
- 1995-09-18 RU RU97106340/13A patent/RU2177999C2/ru active
- 1995-09-18 CZ CZ97875A patent/CZ87597A3/cs unknown
- 1995-09-18 WO PCT/US1995/011859 patent/WO1996009375A1/en not_active Application Discontinuation
- 1995-09-18 NZ NZ293461A patent/NZ293461A/en unknown
- 1995-09-18 JP JP8511012A patent/JPH10506014A/ja active Pending
- 1995-09-18 AU AU35918/95A patent/AU694269B2/en not_active Expired
-
1997
- 1997-03-18 BG BG101338A patent/BG101338A/xx unknown
- 1997-03-21 FI FI971203A patent/FI121507B/fi not_active IP Right Cessation
- 1997-03-21 NO NO971347A patent/NO971347L/no not_active Application Discontinuation
-
2000
- 2000-03-08 US US09/521,526 patent/US6290965B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
RU2177999C2 (ru) | 2002-01-10 |
MX9702209A (es) | 1997-07-31 |
NO971347D0 (no) | 1997-03-21 |
AU3591895A (en) | 1996-04-09 |
BR9509076A (pt) | 1998-07-14 |
PL319294A1 (en) | 1997-08-04 |
AU694269B2 (en) | 1998-07-16 |
CA2200582C (en) | 2007-03-27 |
FI971203A0 (fi) | 1997-03-21 |
FI971203A (fi) | 1997-03-21 |
EP0782615A1 (en) | 1997-07-09 |
SK35897A3 (en) | 1998-02-04 |
NO971347L (no) | 1997-05-21 |
NZ293461A (en) | 1998-04-27 |
HUT77337A (hu) | 1998-03-30 |
US6290965B1 (en) | 2001-09-18 |
CZ87597A3 (cs) | 1998-01-14 |
FI121507B (fi) | 2010-12-15 |
WO1996009375A1 (en) | 1996-03-28 |
JPH10506014A (ja) | 1998-06-16 |
CA2200582A1 (en) | 1996-03-28 |
EP0782615A4 (en) | 2001-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996030520A3 (en) | Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein | |
ZA962245B (en) | Dna encoding human papillomavirus type 18 | |
BG101338A (en) | Dna encoding human papillomavirus type 6a | |
AU4432596A (en) | Purification of 1,3-propanediol | |
ZA961511B (en) | Byproduct stream purification in the preparation of 1,3-propanediol-based polyesters | |
CA2215834A1 (en) | Dna encoding human papillomavirus type 18 | |
EP0683676A4 (en) | BIODISTRIBUTION DIRECTED FROM SMALL MOLECULES. | |
BG102818A (en) | D-manitol and method for its preparation | |
AU4376396A (en) | Use of andrographolide compounds to treat or prevent pathogenicity of diseases | |
GB9615682D0 (en) | The process of asphalt purification and the composition of modified asphalt | |
AU4361696A (en) | New uses of indolo-{2,3b}-quinoxalines | |
BR9706702A (pt) | Purificação de 1,1,1,3,3-pentafluorpropano | |
HRP970224A2 (en) | TREATMENT OF ASTHMA WITH TNFR-Ig | |
IL124415A0 (en) | Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides | |
PL343758A1 (en) | Purification of carboxaldehyde | |
AU5425098A (en) | Compounds and methods to treat infectious diseases | |
PL321001A1 (en) | Monomers of 4,4-disubstituted cyclohexan-1-one and compounds showing affinity to them | |
GB9214449D0 (en) | Purification of 1,1,1,2-tetrafluoroethane | |
GB9414290D0 (en) | Vapour pressure unlimited source of energy | |
MX9707457A (es) | Acido desoxirribonucleico sintetico hibrido l1 de hpv6/11 que codifica proteina l1 de virus de papiloma humano tipo 11. | |
PL321000A1 (en) | 3,3-(disubstituted) monomers of cyclohexan-1-ol and compounds showing affinity to them | |
EP0912595A4 (en) | MOLECULES ASSOCIATED WITH HODGKIN'S DISEASE AND USES THEREOF | |
AU1587295A (en) | The treatment of gaseous substances | |
GB9302184D0 (en) | Improvements relating to the formation of cartosn | |
IL123526A0 (en) | Gas burner of the type known as "living-flame" |